|
Volumn 2, Issue 1, 2002, Pages 19-26
|
Augmentation of apoptosis by the combination of bleomycin with trifluoperazine in the presence of mutant p53
|
Author keywords
Cancer chemotherapy; Cell cycle distribution; L1210 cells; Leukemia
|
Indexed keywords
BLEOMYCIN;
DNA;
PROTEIN BCL 2;
PROTEIN P53;
TRIFLUOPERAZINE;
CALCIUM;
CALMODULIN;
ANIMAL CELL;
ANTINEOPLASTIC ACTIVITY;
APOPTOSIS;
ARTICLE;
CELL CYCLE;
CELL DEATH;
CHROMATIN CONDENSATION;
CONTROLLED STUDY;
CYTOTOXICITY;
DNA CLEAVAGE;
DNA DAMAGE;
DRUG MECHANISM;
GENE OVEREXPRESSION;
IMMUNOASSAY;
LYMPHOCYTE;
NONHODGKIN LYMPHOMA;
NONHUMAN;
PRIORITY JOURNAL;
TREATMENT PLANNING;
ANIMAL;
CELL CULTURE;
DRUG ANTAGONISM;
DRUG EFFECT;
DRUG POTENTIATION;
LEUKEMIA L 1210;
METABOLISM;
MOUSE;
MUTATION;
PATHOLOGY;
TUMOR SUPPRESSOR GENE;
ANIMAL;
APOPTOSIS;
BLEOMYCIN;
CALCIUM;
CALMODULIN;
CELL CYCLE;
DNA DAMAGE;
DRUG SYNERGISM;
GENES, P53;
LEUKEMIA L1210;
MICE;
MUTATION;
PROTO-ONCOGENE PROTEINS C-BCL-2;
SUPPORT, NON-U.S. GOV'T;
SUPPORT, U.S. GOV'T, P.H.S.;
TRIFLUOPERAZINE;
TUMOR CELLS, CULTURED;
ANIMALS;
|
EID: 0036007541
PISSN: 13594117
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1359-4117.2002.01002.x Document Type: Article |
Times cited : (16)
|
References (48)
|